


In colorectal neoplasms care, drug exposure can rarely trigger insulin autoimmune syndrome, where autoantibodies bind insulin and cause unpredictable postprandial hypoglycemia. The key signal is therapy-associated autoimmune hypoglycemia with markedly eleva...
Read more
In colorectal neoplasms care, drug-induced insulin autoimmune syndrome can present with recurrent hypoglycemia driven by insulin autoantibodies that bind and later release endogenous insulin. This case highlights the mechanism, diagnostic pathway using insu...
Read more
Insulin autoimmune syndrome in colorectal cancer care presents as recurrent hypoglycemia driven by insulin autoantibodies that bind and unpredictably release endogenous insulin. A case from oncology highlights that implicated medications can trigger this me...
Read more